Selected research
Industry Research
Ophthalmology AI Screening Software Industry Research Report 2026
Market perspective
The global Ophthalmology AI Screening Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Ophthalmology AI Screening Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Ophthalmology AI Screening Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Ophthalmology AI Screening Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Ophthalmology AI Screening Software include Eyenuk, Inc., DeepMind, Remidio, Retmarker, AEYE Health, RetinaLyze, Synapxe, Intelligent Retinal Imaging Systems and RetinAI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Ophthalmology AI Screening Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Ophthalmology AI Screening Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ophthalmology AI Screening Software Market by Company
Eyenuk, Inc.
DeepMind
Remidio
Retmarker
AEYE Health
RetinaLyze
Synapxe
Intelligent Retinal Imaging Systems
RetinAI
RetinaRisk
CSIRO
Airdoc
Silicon Intelligence
Zhiyuan Huitu
WeDoctor Group
VoxelCloud
Kangfuzi Health
Zhenhealth
Tencent Health
Ophthalmology AI Screening Software Segment by Type
On-premises
Cloud-based
Ophthalmology AI Screening Software Segment by Application
Hospital
Eye Clinic
Medical Research
Others
Ophthalmology AI Screening Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmology AI Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ophthalmology AI Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmology AI Screening Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ophthalmology AI Screening Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-premises
- Cloud-based
Applications
- Hospital
- Eye Clinic
- Medical Research
- Others
Companies covered
- Eyenuk, Inc.
- DeepMind
- Remidio
- Retmarker
- AEYE Health
- RetinaLyze
- Synapxe
- Intelligent Retinal Imaging Systems
- RetinAI
- RetinaRisk
- CSIRO
- Airdoc
- Silicon Intelligence
- Zhiyuan Huitu
- WeDoctor Group
- VoxelCloud
- Kangfuzi Health
- Zhenhealth
- Tencent Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ophthalmology AI Screening Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 On-premises
- 2.2.3 Cloud-based
- 2.3 Ophthalmology AI Screening Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Eye Clinic
- 2.3.4 Medical Research
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Ophthalmology AI Screening Software Breakdown Data by Type
- 3.1 Global Ophthalmology AI Screening Software Historic Market Size by Type (2021-2026)
- 3.2 Global Ophthalmology AI Screening Software Forecasted Market Size by Type (2027-2032)
4 Ophthalmology AI Screening Software Breakdown Data by Application
- 4.1 Global Ophthalmology AI Screening Software Historic Market Size by Application (2021-2026)
- 4.2 Global Ophthalmology AI Screening Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Ophthalmology AI Screening Software Market Perspective (2021-2032)
- 5.2 Global Ophthalmology AI Screening Software Growth Trends by Region
- 5.2.1 Global Ophthalmology AI Screening Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Ophthalmology AI Screening Software Historic Market Size by Region (2021-2026)
- 5.2.3 Ophthalmology AI Screening Software Forecasted Market Size by Region (2027-2032)
- 5.3 Ophthalmology AI Screening Software Market Dynamics
- 5.3.1 Ophthalmology AI Screening Software Industry Trends
- 5.3.2 Ophthalmology AI Screening Software Market Drivers
- 5.3.3 Ophthalmology AI Screening Software Market Challenges
- 5.3.4 Ophthalmology AI Screening Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Ophthalmology AI Screening Software Players by Revenue
- 6.1.1 Global Top Ophthalmology AI Screening Software Players by Revenue (2021-2026)
- 6.1.2 Global Ophthalmology AI Screening Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Ophthalmology AI Screening Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Ophthalmology AI Screening Software Head Office and Area Served
- 6.4 Global Ophthalmology AI Screening Software Players, Product Type & Application
- 6.5 Global Ophthalmology AI Screening Software Manufacturers Established Date
- 6.6 Global Ophthalmology AI Screening Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Ophthalmology AI Screening Software Market Size (2021-2032)
- 7.2 North America Ophthalmology AI Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Ophthalmology AI Screening Software Market Size by Country (2021-2026)
- 7.4 North America Ophthalmology AI Screening Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Ophthalmology AI Screening Software Market Size (2021-2032)
- 8.2 Europe Ophthalmology AI Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Ophthalmology AI Screening Software Market Size by Country (2021-2026)
- 8.4 Europe Ophthalmology AI Screening Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Ophthalmology AI Screening Software Market Size (2021-2032)
- 9.2 Asia-Pacific Ophthalmology AI Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Ophthalmology AI Screening Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Ophthalmology AI Screening Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Ophthalmology AI Screening Software Market Size (2021-2032)
- 10.2 South America Ophthalmology AI Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Ophthalmology AI Screening Software Market Size by Country (2021-2026)
- 10.4 South America Ophthalmology AI Screening Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Ophthalmology AI Screening Software Market Size (2021-2032)
- 11.2 Middle East & Africa Ophthalmology AI Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Ophthalmology AI Screening Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Ophthalmology AI Screening Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eyenuk, Inc.
- 12.1.1 Eyenuk, Inc. Company Information
- 12.1.2 Eyenuk, Inc. Business Overview
- 12.1.3 Eyenuk, Inc. Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.1.4 Eyenuk, Inc. Ophthalmology AI Screening Software Product Portfolio
- 12.1.5 Eyenuk, Inc. Recent Developments
- 12.2 DeepMind
- 12.2.1 DeepMind Company Information
- 12.2.2 DeepMind Business Overview
- 12.2.3 DeepMind Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.2.4 DeepMind Ophthalmology AI Screening Software Product Portfolio
- 12.2.5 DeepMind Recent Developments
- 12.3 Remidio
- 12.3.1 Remidio Company Information
- 12.3.2 Remidio Business Overview
- 12.3.3 Remidio Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.3.4 Remidio Ophthalmology AI Screening Software Product Portfolio
- 12.3.5 Remidio Recent Developments
- 12.4 Retmarker
- 12.4.1 Retmarker Company Information
- 12.4.2 Retmarker Business Overview
- 12.4.3 Retmarker Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.4.4 Retmarker Ophthalmology AI Screening Software Product Portfolio
- 12.4.5 Retmarker Recent Developments
- 12.5 AEYE Health
- 12.5.1 AEYE Health Company Information
- 12.5.2 AEYE Health Business Overview
- 12.5.3 AEYE Health Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.5.4 AEYE Health Ophthalmology AI Screening Software Product Portfolio
- 12.5.5 AEYE Health Recent Developments
- 12.6 RetinaLyze
- 12.6.1 RetinaLyze Company Information
- 12.6.2 RetinaLyze Business Overview
- 12.6.3 RetinaLyze Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.6.4 RetinaLyze Ophthalmology AI Screening Software Product Portfolio
- 12.6.5 RetinaLyze Recent Developments
- 12.7 Synapxe
- 12.7.1 Synapxe Company Information
- 12.7.2 Synapxe Business Overview
- 12.7.3 Synapxe Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.7.4 Synapxe Ophthalmology AI Screening Software Product Portfolio
- 12.7.5 Synapxe Recent Developments
- 12.8 Intelligent Retinal Imaging Systems
- 12.8.1 Intelligent Retinal Imaging Systems Company Information
- 12.8.2 Intelligent Retinal Imaging Systems Business Overview
- 12.8.3 Intelligent Retinal Imaging Systems Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.8.4 Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Product Portfolio
- 12.8.5 Intelligent Retinal Imaging Systems Recent Developments
- 12.9 RetinAI
- 12.9.1 RetinAI Company Information
- 12.9.2 RetinAI Business Overview
- 12.9.3 RetinAI Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.9.4 RetinAI Ophthalmology AI Screening Software Product Portfolio
- 12.9.5 RetinAI Recent Developments
- 12.10 RetinaRisk
- 12.10.1 RetinaRisk Company Information
- 12.10.2 RetinaRisk Business Overview
- 12.10.3 RetinaRisk Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.10.4 RetinaRisk Ophthalmology AI Screening Software Product Portfolio
- 12.10.5 RetinaRisk Recent Developments
- 12.11 CSIRO
- 12.11.1 CSIRO Company Information
- 12.11.2 CSIRO Business Overview
- 12.11.3 CSIRO Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.11.4 CSIRO Ophthalmology AI Screening Software Product Portfolio
- 12.11.5 CSIRO Recent Developments
- 12.12 Airdoc
- 12.12.1 Airdoc Company Information
- 12.12.2 Airdoc Business Overview
- 12.12.3 Airdoc Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.12.4 Airdoc Ophthalmology AI Screening Software Product Portfolio
- 12.12.5 Airdoc Recent Developments
- 12.13 Silicon Intelligence
- 12.13.1 Silicon Intelligence Company Information
- 12.13.2 Silicon Intelligence Business Overview
- 12.13.3 Silicon Intelligence Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.13.4 Silicon Intelligence Ophthalmology AI Screening Software Product Portfolio
- 12.13.5 Silicon Intelligence Recent Developments
- 12.14 Zhiyuan Huitu
- 12.14.1 Zhiyuan Huitu Company Information
- 12.14.2 Zhiyuan Huitu Business Overview
- 12.14.3 Zhiyuan Huitu Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.14.4 Zhiyuan Huitu Ophthalmology AI Screening Software Product Portfolio
- 12.14.5 Zhiyuan Huitu Recent Developments
- 12.15 WeDoctor Group
- 12.15.1 WeDoctor Group Company Information
- 12.15.2 WeDoctor Group Business Overview
- 12.15.3 WeDoctor Group Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.15.4 WeDoctor Group Ophthalmology AI Screening Software Product Portfolio
- 12.15.5 WeDoctor Group Recent Developments
- 12.16 VoxelCloud
- 12.16.1 VoxelCloud Company Information
- 12.16.2 VoxelCloud Business Overview
- 12.16.3 VoxelCloud Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.16.4 VoxelCloud Ophthalmology AI Screening Software Product Portfolio
- 12.16.5 VoxelCloud Recent Developments
- 12.17 Kangfuzi Health
- 12.17.1 Kangfuzi Health Company Information
- 12.17.2 Kangfuzi Health Business Overview
- 12.17.3 Kangfuzi Health Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.17.4 Kangfuzi Health Ophthalmology AI Screening Software Product Portfolio
- 12.17.5 Kangfuzi Health Recent Developments
- 12.18 Zhenhealth
- 12.18.1 Zhenhealth Company Information
- 12.18.2 Zhenhealth Business Overview
- 12.18.3 Zhenhealth Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.18.4 Zhenhealth Ophthalmology AI Screening Software Product Portfolio
- 12.18.5 Zhenhealth Recent Developments
- 12.19 Tencent Health
- 12.19.1 Tencent Health Company Information
- 12.19.2 Tencent Health Business Overview
- 12.19.3 Tencent Health Revenue in Ophthalmology AI Screening Software Business (2021-2026)
- 12.19.4 Tencent Health Ophthalmology AI Screening Software Product Portfolio
- 12.19.5 Tencent Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst